×
Enjoying ad-free content?
Since July 1, 2024, we have disabled all ads to improve your reading experience.
This commitment costs us $10,000 a month. Your support can help us fill the gap.
Support us
Our journalism is banned in Russia. We need your help to keep providing you with the truth.

Elderly Coronavirus Vaccine Recipients ‘Healthy,’ Russian Developer Says

Sputnik V’s registration last month as the world’s first coronavirus vaccine before large-scale clinical trials has sparked controversy. Sergei Kiselyov / Moskva News Agency

Elderly scientists who helped develop Russia’s Sputnik V coronavirus vaccine have not reported adverse effects after being injected, the head of the research institute behind the inoculation told the state-run RIA Novosti news agency Wednesday.

Sputnik V’s registration last month as the world’s first coronavirus vaccine before large-scale clinical trials has sparked questions over its effectiveness and safety. Experts have warned it could cause harm to patients aged 60 and older, who develop more severe forms of Covid-19 and have the highest death rates.

Alexander Gintsburg, the head of Moscow’s state-run Gamaleya Institute which developed the vaccine, said that around a dozen of its employees aged between 70 and 80 had taken the shots and did not report complications.

“They’re all fit, healthy, active, they’re giving lectures, managing patients and playing sports,” Gintsburg told RIA Novosti.

“The vaccination did not affect them in any way,” he added.

Gintsburg, 68, has said he has also taken the adenoviral vector-based vaccine.

His remarks came amid a flurry of reports saying that several high-level Russian government officials have taken the Sputnik V vaccine over the past weeks.

A Bloomberg report in July suggested that “several hundred” Russian business and political leaders have inoculated themselves with the potential vaccine since April, months before its early trials and registration.

Health officials said this week that only 2,500 out of 40,000 volunteers have been recruited for Phase 3 trials of Sputnik V so far.

Gintsburg told RIA Novosti on Wednesday that volunteers in the 60-80 age group will be recruited among the residents of Moscow.

“I hope that what I just told you will be officially confirmed and the vaccine will be allowed to be used for older people,” Gintsburg said.

… we have a small favor to ask. As you may have heard, The Moscow Times, an independent news source for over 30 years, has been unjustly branded as a "foreign agent" by the Russian government. This blatant attempt to silence our voice is a direct assault on the integrity of journalism and the values we hold dear.

We, the journalists of The Moscow Times, refuse to be silenced. Our commitment to providing accurate and unbiased reporting on Russia remains unshaken. But we need your help to continue our critical mission.

Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and you can be confident that you're making a significant impact every month by supporting open, independent journalism. Thank you.

Once
Monthly
Annual
Continue
paiment methods
Not ready to support today?
Remind me later.

Read more